Adjuvant trastuzumab: progress, controversies, and the steps ahead

por Joy, A.A., Mackey, J.R.
Publicado 2006

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

por Michelakis, E D, Webster, L, Mackey, J R
Publicado 2008

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group

por Mackey, J.R., Clemons, M., Côté, M.A., Delgado, D., Dent, S., Paterson, A., Provencher, L., Sawyer, M.B., Verma, S.
Publicado 2008

Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin

por Lam, L, Aktary, Z, Bishay, M, Werkman, C, Kuo, C-Y, Heacock, M, Srivastava, N, Mackey, J R, Pasdar, M
Publicado 2012

Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes

por Perrone, G., Morini, S., Santini, D., Rabitti, C., Vincenzi, B., Alloni, R., Antinori, A., Magistrelli, P., Lai, R., Cass, C., Mackey, J.R., Coppola, R., Tonini, G., Onetti Muda, A.
Publicado 2010

Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy

por Courneya, K S, McKenzie, D C, Mackey, J R, Gelmon, K, Friedenreich, C M, Yasui, Y, Reid, R D, Vallerand, J R, Adams, S C, Proulx, C, Dolan, L B, Wooding, E, Segal, R J
Publicado 2014

Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study

por Glass, O K, Inman, B A, Broadwater, G, Courneya, K S, Mackey, J R, Goruk, S, Nelson, E R, Jasper, J, Field, C J, Bain, J R, Muehlbauer, M, Stevens, R D, Hirschey, M D, Jones, L W
Publicado 2015

Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab

por Arnold, D, Fuchs, C S, Tabernero, J, Ohtsu, A, Zhu, A X, Garon, E B, Mackey, J R, Paz-Ares, L, Baron, A D, Okusaka, T, Yoshino, T, Yoon, H H, Das, M, Ferry, D, Zhang, Y, Lin, Y, Binder, P, Sashegyi, A, Chau, I
Publicado 2017

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given...

por Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G., Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, A., Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W.
Publicado 2018

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

por Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G, Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, Alan, Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W.
Publicado 2018